Literature DB >> 27113701

Risk factors for postpartum glucose intolerance in women with gestational diabetes mellitus.

Nobue Kojima1, Kenji Tanimura1, Masashi Deguchi1, Mayumi Morizane1, Yushi Hirota2, Wataru Ogawa2, Hideto Yamada1.   

Abstract

OBJECTIVES: To determine the risk factors for glucose intolerance (GI) during the postpartum period in women with gestational diabetes mellitus (GDM).
METHODS: This prospective cohort study included 72 Japanese women with GDM who underwent 75 g oral glucose tolerance tests (OGTT) at 12 weeks after delivery. These women were divided into the GI group and the normal group based on postpartum OGTT. Risk factors for GI, including levels of blood glucose (BG), area under the curve (AUC) of glucose, AUC insulin, HbA1c, homeostasis model assessment-insulin resistance (HOMA-IR), HOMA-β, insulinogenic index (II) and the oral disposition index (DI) in antepartum OGTT, were analyzed by logistic regression analyses.
RESULTS: Of the 72 women, 60 (83.3%) were normal and 12 (16.7%) had GI. By univariate logistic regression analyses, fasting BG, AUC glucose, HOMA-β, II and oral DI were selected as risk factors for GI. Multivariate logistic regression analysis revealed that the level of II in antepartum OGTT was a significant factor that predicted GI after delivery (odds ratio, 0.008; 95% CI, 0.0001-0.9; p < 0.05).
CONCLUSIONS: II measured by OGTT during pregnancy might be a useful predictor of GI within the early postpartum period in women with GDM.

Entities:  

Keywords:  75 g oral glucose tolerance tests; gestational diabetes mellitus; glucose intolerance; insulinogenic index; postpartum

Mesh:

Year:  2016        PMID: 27113701     DOI: 10.1080/09513590.2016.1177009

Source DB:  PubMed          Journal:  Gynecol Endocrinol        ISSN: 0951-3590            Impact factor:   2.260


  7 in total

Review 1.  Postpartum glucose intolerance: an updated overview.

Authors:  Ida Pastore; Eusebio Chiefari; Raffaella Vero; Antonio Brunetti
Journal:  Endocrine       Date:  2017-08-14       Impact factor: 3.633

2.  Impact of Risk Factors on Short and Long-Term Maternal and Neonatal Outcomes in Women With Gestational Diabetes Mellitus: A Prospective Longitudinal Cohort Study.

Authors:  Antonella Corcillo; Dan Yedu Quansah; Christophe Kosinski; Katrien Benhalima; Jardena J Puder
Journal:  Front Endocrinol (Lausanne)       Date:  2022-06-20       Impact factor: 6.055

3.  Prediction of Gestational Diabetes Mellitus and Pre-diabetes 5 Years Postpartum using 75 g Oral Glucose Tolerance Test at 14-16 Weeks' Gestation.

Authors:  Tove Lekva; Kristin Godang; Annika E Michelsen; Elisabeth Qvigstad; Kjersti Ringvoll Normann; Errol R Norwitz; Pål Aukrust; Tore Henriksen; Jens Bollerslev; Marie Cecilie Paasche Roland; Thor Ueland
Journal:  Sci Rep       Date:  2018-09-06       Impact factor: 4.379

4.  Lactation and progression to type 2 diabetes in patients with gestational diabetes mellitus: A systematic review and meta-analysis of cohort studies.

Authors:  Lijun Feng; Qunli Xu; Zhefang Hu; Hongying Pan
Journal:  J Diabetes Investig       Date:  2018-04-18       Impact factor: 4.232

5.  Clinical and genetic characteristics of abnormal glucose tolerance in Japanese women in the first year after gestational diabetes mellitus.

Authors:  Yoshifumi Kasuga; Kei Miyakoshi; Atsushi Tajima; Yoshifumi Saisho; Satoru Ikenoue; Daigo Ochiai; Tadashi Matsumoto; Naoko Arata; Kenichiro Hata; Mamoru Tanaka
Journal:  J Diabetes Investig       Date:  2018-10-26       Impact factor: 4.232

6.  Predictors of postpartum glucose intolerance in women with gestational diabetes mellitus: a prospective cohort study in Ethiopia based on the updated diagnostic criteria.

Authors:  Achenef Asmamaw Muche; Oladapo O Olayemi; Yigzaw Kebede Gete
Journal:  BMJ Open       Date:  2020-08-31       Impact factor: 2.692

7.  Clinical utility of 1-month postpartum random plasma glucose and glycated hemoglobin combined with pre-pregnancy body mass index for detecting postpartum glucose intolerance in Japanese women with gestational diabetes.

Authors:  Kazutoshi Sugiyama; Yoshifumi Saisho; Yoshifumi Kasuga; Daigo Ochiai; Hiroshi Itoh
Journal:  J Diabetes Investig       Date:  2021-07-28       Impact factor: 4.232

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.